| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 43.263 | 37.680 | 37.824 | 31.753 | 43.074 | 34.813 | 40.615 | 36.944 | 20.222 | 31.423 |
| Total Income - EUR | 43.627 | 38.207 | 38.264 | 32.043 | 46.085 | 34.821 | 40.862 | 36.947 | 31.555 | 31.423 |
| Total Expenses - EUR | 15.739 | 14.973 | 14.088 | 16.670 | 17.150 | 22.386 | 22.294 | 24.135 | 31.146 | 29.879 |
| Gross Profit/Loss - EUR | 27.888 | 23.234 | 24.176 | 15.373 | 28.935 | 12.436 | 18.568 | 12.813 | 409 | 1.543 |
| Net Profit/Loss - EUR | 26.585 | 22.478 | 23.794 | 15.053 | 28.474 | 12.095 | 18.241 | 12.443 | 93 | 601 |
| Employees | 2 | 2 | 3 | 3 | 1 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Medicor-Dr. Giuca Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.919 | 1.870 | 836 | 33.472 | 29.577 | 25.610 | 20.854 | 17.013 | 14.592 | 8.885 |
| Current Assets | 33.049 | 29.204 | 37.320 | 5.927 | 16.942 | 33.611 | 13.765 | 29.770 | 24.308 | 10.357 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 745 | 725 | 1.046 | 929 | 2.974 | 2.334 | 2.349 | 1.442 | 864 | 4.437 |
| Cash | 32.303 | 28.480 | 36.274 | 4.998 | 13.968 | 31.277 | 11.416 | 28.328 | 23.443 | 5.921 |
| Shareholders Funds | 34.632 | 22.531 | 23.846 | 15.104 | 28.525 | 40.079 | 30.116 | 12.492 | 12.547 | 649 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.393 | 8.600 | 14.309 | 24.295 | 18.030 | 19.142 | 4.411 | 35.143 | 26.246 | 18.646 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medicor-Dr. Giuca Srl